Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Hana Micron (067310) – Investor Relations (IR) Holding / 2025-08-12

Posted on August 12, 2025August 2, 2026 By K-STOCK Editor No Comments on [Disclosure] Hana Micron (067310) – Investor Relations (IR) Holding / 2025-08-12

Fact Source: Financial Supervisory Service DART

💡 Executive Summary

Hana Micron will hold an IR session both online and offline for domestic and foreign institutional investors, analysts, and individual investors to present its H1 2025 business performance.

📊 Key Disclosure Content & Financial Figures Summary

  1. Company Name: Hana Micron Inc.
  2. Date & Time: August 27, 2025 (14:30 ~ 15:30 local time)
  3. Location: Room 901, Financial Investment Education Center, Yeouido
  4. Target Audience: Domestic and foreign institutional investors, analysts, and individual investors
  5. Purpose: Explanation of H1 2025 business performance and enhancing investor understanding
  6. Format:
    • Presentation and Q&A (Multi-party face-to-face meeting)
    • Simultaneous offline and online (Zoom) execution (Webcasting URL: https://us05web.zoom.us/j/2605478546)
  7. Main Content: Explanation of H1 2025 business performance, key business conditions, and Q&A
  8. Sponsor: Not specified
  9. IR Material Posting:
    • Date & Time: August 27, 2025 at 14:00
    • Location: Company website (https://www.hanamicron.com) and Korea Exchange KIND System (https://kind.krx.co.kr) ‘IR Library’

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Reviewing Published IR Materials and Official Half-Yearly Reports

This filing announces an Investor Relations event organized to explain H1 2025 operating results to institutional and individual investors. Checking the presentation slides posted on the company’s website or the Korea Exchange KIND system on the event day is important for examining specific H1 performance details and management updates. Official financial results and detailed business operations can be verified through the company’s IR repository, KIND, and official filings such as Half-Yearly Reports.

📢 Disclaimer & Source Information

Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Disclaimer: This content is provided solely for information purposes and linguistic reference. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific securities. All investment decisions and financial risks rest solely with the investor.

Contact: For compliance inquiries or copyright-related issues, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] Celltrion (068270) – Additional Listing (Exercise of Stock Options) / 2025-08-11
Next Post: [Disclosure] ISU PETASYS(007660) – Investor Relations (IR) Holding Announcement / 2025-08-12

Related Posts

[Disclosure] SK Square (402340) – Decision on New Facility Investment / 2024-04-24 Semiconductors
[Disclosure] SK square(402340) – Relisting due to Modification (Retirement of Shares) / 2025-12-12 Semiconductors
[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan for CT-P13 SC (Zymfentra) in Europe (Part 1 & 2) (Rheumatoid Arthritis Patients) / 2024-12-17 Disclosures
[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Holding / 2026-04-10 Semiconductors
[Disclosure] Hanwha Aerospace (012450) Announces Fatal Accident at Geoje Shipyard of Major Subsidiary Hanwha Ocean Co., Ltd. Disclosures
[Disclosure] Celltrion (068270) – Approval of IND Amendment for CT-P55 (Cosentyx Biosimilar) U.S. Phase 3 Clinical Trial / 2026-05-12 Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme